Outcome of patients with Myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMT
Jazyk angličtina Země Anglie, Velká Británie Médium print-electronic
Typ dokumentu časopisecké články
PubMed
29808926
DOI
10.1111/bjh.15407
Knihovny.cz E-zdroje
- Klíčová slova
- JAK inhibitors, allogeneic stem cell transplant, fibrosis, mylelofibrosis, relapse,
- MeSH
- analýza přežití MeSH
- dospělí MeSH
- farmakoterapie MeSH
- homologní transplantace MeSH
- lidé středního věku MeSH
- lidé MeSH
- management nemoci MeSH
- primární myelofibróza mortalita terapie MeSH
- recidiva MeSH
- retrospektivní studie MeSH
- transfuze lymfocytů MeSH
- transplantace hematopoetických kmenových buněk metody MeSH
- výsledek terapie MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
Allogeneic Haematopoietic Stem Cell Transplant (allo-HSCT) remains the only curative approach for Myelofibrosis (MF). Scarce information exists in the literature on the outcome and, indeed, management of those MF patients who relapse following transplant. We hereby report on the management and outcome of 202 patients who relapsed post allo-HSCT for MF.
CHU de Lille LIRIC INSERM U995 Universite de Lille Lille France
Clinic for Cancer Surgery and Transplantation Oslo University Hospital Rikshospitalet Norway
Comprehensive Cancer Centre Division of Haematology King's College London
Department of Haematology and Oncology University of Regensburg Regensburg Germany
Department of Haematology Hopital d`Enfants Nancy France
Department of Haematology Karolinska University Hospital Stockholm Sweden
Department of Haematology Radboud University Medical Centre Nijmegen the Netherlands
Department of Haematology University of Liege Liege Belgium
Division of Haematology Geneva University Hospitals Geneva Switzerland
EBMT Data Office University Medical Centre Leiden the Netherlands
Erasmus MC Cancer Institute University Medical Centre Rotterdam the Netherlands
Hammersmith Hospital NHS Foundation Trust London United Kingdom
Institute of Haematology and Blood Transfusion Prague Czech Republic
Ospedale San Martino Genova Italy
Service d'hématologie clinique Adulte et pédiatrie CHU ESTAING Clermont France
Service d'Hématologie Greffe Hôpital Saint Louis Assistance Publique Hôpitaux de Paris Paris France
Stem Cell Transplant Unit Turku University Hospital Turku Finland
University Hospital Eppendorf Hamburg Germany
Citace poskytuje Crossref.org
